Free Trial
→ How to claim a stake in SpaceX before the June 12 IPO (From Brownstone Research) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$20.35 -0.32 (-1.54%)
As of 02:02 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

FBIOP vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Fortress Biotech stock or one of its competitors? MarketBeat compares Fortress Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortress Biotech include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Fortress Biotech compare to Ainos?

Ainos (NASDAQ:AIMDW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

In the previous week, Ainos had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Fortress Biotech. Ainos' average media sentiment score of 0.98 beat Fortress Biotech's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
Fortress Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Ainos beats Fortress Biotech on 2 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Alvotech?

Fortress Biotech (NASDAQ:FBIOP) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

In the previous week, Fortress Biotech's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Fortress Biotech Neutral
Alvotech Neutral

Summary

Alvotech beats Fortress Biotech on 1 of the 1 factors compared between the two stocks.

How does Fortress Biotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Fortress Biotech Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Aravive beats Fortress Biotech on 2 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Fortress Biotech (NASDAQ:FBIOP) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Fortress Biotech N/A N/A N/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Fortress Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

Summary

Fortress Biotech beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Fortress Biotech compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Fortress Biotech Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

Summary

Fortress Biotech beats Biofrontera on 1 of the 1 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$437.93M$6.44B$12.11B
Dividend Yield12.11%3.86%2.67%5.56%
P/E RatioN/A3.2023.8123.78
Price / SalesN/A6,461.99480.0386.80
Price / CashN/A13.1326.9937.25
Price / BookN/A85.1110.356.74
Net IncomeN/A-$96.07M$3.57B$337.72M
7 Day Performance-0.63%-2.00%-1.35%-2.91%
1 Month Performance50.75%1.20%3.13%1.65%
1 Year Performance114.90%64.62%23.57%26.91%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$20.35
-1.5%		N/A+118.3%$0.00$66.16MN/A170
AIMDW
Ainos
N/A$0.12
-1.6%		N/A+13.7%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.27
+49.8%		N/A-92.7%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
-35.3%		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners
America's AI Future Needs a Domestic Fuel Chain
AI dominance requires power at a scale most investors have not priced in - and nuclear energy is emerging as a...
i2i Marketing Group, LLC | Sponsoredtc pixel
Tiny Nasdaq Firm Lands €13.9 Million Semiconductor Deal
One small Nasdaq-listed company just landed a 13.9 million euro contract tied to a new advanced-node semicondu...
Finplays | Sponsoredtc pixel
Important SpaceX PREDICTION
The biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian s...
Banyan Hill Publishing | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your name isn't on our protected list yet
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...
American Alternative | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel